Table 4.
Adverse Events Associated with Keratoplasty for Corneal Endothelial Disease
| Year | # of keratoplasties | Severe Adverse Events* | Endophthalmitis | Suprachoroidal Hemorrhage | Rhegmatogenous Retinal Detachment | ||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
| |||||||||||||||||||||||||
| total | ≤90 days | >90 days | total | ≤90 days | >90 days | total | ≤90 days | >90 days | total | ≤90 days | >90 days | ||||||||||||||
|
| |||||||||||||||||||||||||
| # | % | # | % | # | % | # | % | # | % | # | % | # | % | # | % | # | % | # | % | # | % | # | % | ||
| 2002 | 128 | 6 | 4.69 | 2 | 1.56 | 4 | 3.13 | 1 | 0.78 | 1 | 0.78 | 0 | 0 | 1 | 0.78 | 1 | 0.78 | 0 | 0 | 5 | 3.91 | 0 | 0 | 5 | 3.91 |
| 2002.5 | 105 | 3 | 2.86 | 2 | 1.9 | 1 | 0.95 | 2 | 1.9 | 1 | 0.95 | 1 | 0.95 | 1 | 0.95 | 1 | 0.95 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| 2003 | 121 | 4 | 3.31 | 3 | 2.48 | 1 | 0.83 | 1 | 0.83 | 0 | 0 | 1 | 0.83 | 1 | 0.83 | 1 | 0.83 | 0 | 0 | 2 | 1.65 | 2 | 1.65 | 0 | 0 |
| 2003.5 | 112 | 4 | 3.57 | 4 | 3.57 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 2 | 1.79 | 1 | 0.89 | 1 | 0.89 | 3 | 2.68 | 2 | 1.79 | 1 | 0.89 |
| 2004 | 116 | 5 | 4.31 | 1 | 0.86 | 4 | 3.45 | 1 | 0.86 | 1 | 0.86 | 0 | 0 | 1 | 0.86 | 0 | 0 | 1 | 0.86 | 4 | 3.45 | 0 | 0 | 4 | 3.45 |
| 2004.5 | 113 | 5 | 4.42 | 2 | 1.77 | 3 | 2.65 | 1 | 0.88 | 1 | 0.88 | 0 | 0 | 1 | 0.88 | 0 | 0 | 1 | 0.88 | 4 | 3.54 | 1 | 0.88 | 3 | 2.65 |
| 2005 | 126 | 5 | 3.97 | 1 | 0.79 | 4 | 3.17 | 2 | 1.59 | 0 | 0 | 2 | 1.59 | 2 | 1.59 | 0 | 0 | 2 | 1.59 | 1 | 0.79 | 1 | 0.79 | 0 | 0 |
| 2005.5 | 135 | 6 | 4.44 | 3 | 2.22 | 3 | 2.22 | 3 | 2.22 | 2 | 1.48 | 1 | 0.74 | 1 | 0.74 | 1 | 0.74 | 0 | 0 | 2 | 1.48 | 0 | 0 | 2 | 1.48 |
| 2006 | 116 | 5 | 4.31 | 3 | 2.59 | 2 | 1.72 | 3 | 2.59 | 2 | 1.72 | 1 | 0.86 | 0 | 0 | 0 | 0 | 0 | 0 | 2 | 1.72 | 1 | 0.86 | 1 | 0.86 |
| 2006.5 | 103 | 1 | 0.97 | 0 | 0 | 1 | 0.97 | 1 | 0.97 | 0 | 0 | 1 | 0.97 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| 2007 | 123 | 4 | 3.25 | 3 | 2.44 | 1 | 0.81 | 2 | 1.63 | 2 | 1.63 | 0 | 0 | 1 | 0.81 | 1 | 0.81 | 0 | 0 | 3 | 2.44 | 2 | 1.63 | 1 | 0.81 |
| 2007.5 | 142 | 4 | 2.82 | 2 | 1.41 | 2 | 1.41 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 4 | 2.82 | 2 | 1.41 | 2 | 1.41 |
| 2008 | 126 | 4 | 3.17 | 2 | 1.59 | 2 | 1.59 | 1 | 0.79 | 0 | 0 | 1 | 0.79 | 0 | 0 | 0 | 0 | 0 | 0 | 3 | 2.38 | 1 | 0.79 | 2 | 1.59 |
| 2008.5 | 133 | 3 | 2.26 | 2 | 1.5 | 1 | 0.75 | 2 | 1.5 | 0 | 0 | 2 | 1.5 | 1 | 0.75 | 1 | 0.75 | 0 | 0 | 3 | 2.26 | 2 | 1.5 | 1 | 0.75 |
|
| |||||||||||||||||||||||||
| 2002–2008 | 1,699 | 59 | 3.45 | 30 | 1.76 | 29 | 1.69 | 20 | 1.18 | 10 | 0.59 | 10 | 0.59 | 12 | 0.71 | 7 | 0.41 | 5 | 0.30 | 36 | 2.08 | 14 | 0.81 | 22 | 1.27 |
*
Severe postoperative adverse events include endophthalmitis, suprachoroidal hemorrhage, and rhegmatogenous retinal detachment.